BOLLA, GIOVANNI BATTISTA
 Distribuzione geografica
Continente #
EU - Europa 7.509
NA - Nord America 5.998
AS - Asia 4.677
SA - Sud America 390
AF - Africa 120
Continente sconosciuto - Info sul continente non disponibili 25
OC - Oceania 21
Totale 18.740
Nazione #
US - Stati Uniti d'America 5.894
IT - Italia 2.840
GB - Regno Unito 2.043
CN - Cina 1.390
SG - Singapore 1.301
RU - Federazione Russa 538
VN - Vietnam 467
DE - Germania 399
HK - Hong Kong 388
SE - Svezia 306
TR - Turchia 296
UA - Ucraina 281
NL - Olanda 273
BR - Brasile 271
FR - Francia 248
IN - India 237
KR - Corea 229
IE - Irlanda 208
BD - Bangladesh 157
EU - Europa 141
FI - Finlandia 137
PL - Polonia 101
CI - Costa d'Avorio 63
CO - Colombia 58
CA - Canada 53
ID - Indonesia 47
JP - Giappone 39
BE - Belgio 26
AR - Argentina 25
MX - Messico 24
GR - Grecia 23
ES - Italia 19
IQ - Iraq 15
CH - Svizzera 14
ZA - Sudafrica 14
AU - Australia 13
TH - Thailandia 11
VE - Venezuela 11
LU - Lussemburgo 10
PH - Filippine 10
UZ - Uzbekistan 10
MY - Malesia 9
CR - Costa Rica 8
MA - Marocco 8
RO - Romania 8
TW - Taiwan 8
NZ - Nuova Zelanda 7
PK - Pakistan 7
SA - Arabia Saudita 7
CL - Cile 6
JO - Giordania 6
NP - Nepal 6
PY - Paraguay 6
KE - Kenya 5
PT - Portogallo 5
AT - Austria 4
DZ - Algeria 4
EC - Ecuador 4
EG - Egitto 4
GT - Guatemala 4
HN - Honduras 4
IL - Israele 4
JM - Giamaica 4
KG - Kirghizistan 4
KZ - Kazakistan 4
PE - Perù 4
SC - Seychelles 4
AO - Angola 3
AZ - Azerbaigian 3
DK - Danimarca 3
IR - Iran 3
LT - Lituania 3
LV - Lettonia 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
CD - Congo 2
CZ - Repubblica Ceca 2
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
LB - Libano 2
MO - Macao, regione amministrativa speciale della Cina 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
AD - Andorra 1
BT - Bhutan 1
BY - Bielorussia 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
HR - Croazia 1
IS - Islanda 1
KH - Cambogia 1
Totale 18.838
Città #
Southend 1.920
Singapore 773
Boise 710
Milan 464
Ashburn 430
Hong Kong 358
San Jose 344
Seattle 343
Chandler 342
Beijing 308
Princeton 224
Jacksonville 220
Dublin 208
Wilmington 192
Redmond 176
Santa Clara 167
Dallas 159
Council Bluffs 154
Rome 149
Boardman 121
Ho Chi Minh City 118
Mountain View 118
Bengaluru 117
Los Angeles 111
Ann Arbor 106
Sakarya 106
Nanjing 100
Fairfield 97
Lauterbourg 92
Hanoi 91
Guangzhou 90
Serra 87
Warsaw 86
Des Moines 80
Moscow 76
Woodbridge 72
Buffalo 69
Turin 64
Abidjan 63
New York 63
Dearborn 62
Frankfurt am Main 56
Margão 56
Andover 55
Bogotá 54
Lowell 50
Shanghai 49
Dong Ket 48
Houston 45
Somerville 45
Payette 43
Cangzhou 41
Bitonto 37
Columbus 37
Tianjin 37
The Dalles 36
Florence 35
Jerome 35
Phoenix 35
Berlin 34
Cottonwood 34
Shenyang 34
Jinan 33
Hefei 32
Orofino 32
Nanchang 31
Tokyo 31
Garden Valley 30
Naples 29
Redwood City 29
Cambridge 27
Istanbul 26
Lewiston 26
Jakarta 24
Palermo 24
Bari 23
Shenzhen 23
Haiphong 22
Helsinki 22
San Diego 22
Da Nang 21
São Paulo 21
Verona 20
Brescia 19
Monza 19
Bologna 18
Changsha 18
Nordman 18
Brussels 17
Genoa 17
Athens 16
Hangzhou 16
Toronto 16
Munich 15
Torino 15
Catania 14
Kunming 14
Eitensheim 13
Fuzhou 13
London 13
Totale 11.345
Nome #
Efficacia e tollerabilità di barnidipina vs amlodipina in un gruppo di pazienti ipertesi 2.277
Effetti del valsartan sulla riduzione della massa ventricolare sinistra e sui livelli di PICP nei pazienti ipertesi 1.170
Antypertensive effect of barnidipine 10 mg or amlodipine 5 to 10 mg once daily in treatment-naive patients with essential hypertension: A 24-week, randomized, open-label, Pilot Study 365
Elevated serum procollagen type III peptide in splanchnic and peripheral circulation of patients with inflammatory bowel disease submitted to surgery 319
Adrenergic and reflex abnormalities in obesity-related hypertension 292
Barnidipine is equally effective but safer than amlodipine in never treated esential hypertensive patients 275
L’aumento del drive simpatico che si osserva durante bypass aortocoronarico correla con l’espressione delle citochine proinfiammatorie ed é attenuato dalla terapia betabloccante 272
A bioclinical pattern for the early diagnosis of cardioembolic stroke 271
Effects of valsartan on the reduction of the left ventricular mass and procollagen levels in hypertensive patients 267
Nitric oxide and aldosterone secretion in human hypertension 263
Efficacy and tolerability of barnidipine compared to amlodipine in a group of hypertensive patients: a preliminary report 250
Aminoterminal propeptide of type III procollagen as a new seromarker in ulcerative colitis 247
La sindrome metabolica è caratterizzata da un ipertono adrenergico indipendentemente dalla presenza di obesità 234
Increased myocardial reflectivity in hypertensive patients: a preliminary report 223
Effects of AT1 blockers on left atrium dimension and pro-BNP levels in hypertensive patients 221
Mesenchymal stem cells : potential for therapy and treatment of chronic non-healing skin wounds 221
Caratteristiche di rimodellamento vascolare e funzione endoteliale nelle arteriole di resistenza di pazienti affetti da obesità viscerale grave 210
Studio dei valori di procollagene III nei pazienti affetti da IBD 210
Increased serum procollagen type III peptide in splanchnic and peripheral circulation of patients with Crohn disease submitted to surgery 204
[The roll-over test in pregnancy: physiopathologic and clinical aspects] 201
Benefici della terapia antiipertensiva nella riduzione del danno d'organo : la diminuzione del procollagene I e III in un gruppo di ipertesi trattati 201
Cardiopulmonary reflex before and after regression of left ventricular hypertrophy in essential hypertension 200
Effects of Valsartan treatment indicators of cardiovascular damage in newly diagnosed hypertensive patients: a prospective, twelve-month open-label pilot study 199
Behaviour of regional adrenergic outflow in mild-to-moderate renal failure 198
Adrenergic,metabolic,and reflex abnormalities in reverse and extreme dipper hypertensives 197
Beta-blockers reduce myocardial brain natriuretic peptide release after coronary artery bypass grafts 185
Efects of Sacubitril/Valsartan on biomarkers of fbrosis and infammation in patients with heart failure with reduced ejection fraction 182
Multiple sampling improves norepinephrine reproducibility in essential hypertension : a comparison with the microneurographic technique 181
Benefici della terapia antiipertensiva nella riduzione del danno d'organo : la riduzione del procollagene I e III in un gruppo di pazienti ipertesi trattati 177
Reduction of target organ damage induced by AT1 antagonist therapy : effect of Valsartan after 1 years of follow-up 174
Excessive sympathetic activation in heart failure with obesity and metabolic syndrome : characteristics and mechanisms 174
Radial artery compliance in young, obese, normotensive subjects 174
Barnidipine is equally effective but safer than amlodipine in never treated essential hypertensive patients 167
Correlation between norepinephrine and epinephrine myocardial spillover and tumor necrosis factor-alpha in conventional versus off-pump coronary artery bypass surgery 162
Clinical and functional correlates of platelet cyclic GMP in essential hypertensives 162
Sympathetic activation in congestive heart failure : Reproducibility of neuroadrenergic markers 157
Alterazioni neuroadrenergichee baroriflesse nell'ipertensione associata a disfunzione diastolica del ventricolo sinistro 156
Effetti del downloading chirurgico ventricolare sul release polmonare e miocardico di noradrenalina e di adrenalina 154
Effects of erythropoietin administration on blood pressure and urinary albumin excretion in rats 153
Impact of the metabolic syndrome on subcutaneous microcirculation in obese patients 152
Does nitric oxide inhibit aldosterone secretion in human hypertension? 150
Heart rate as a sympathetic marker during acute adrenergic challenge 150
Effects of left ventricular diastolic dysfunction on neuroadrenergic and baroreflex alterations in essential hypertension 148
Effetti della disfunzione distolica del ventricolo sinistro sulle alterazioni neuroadrenergiche e baroriflesse nell'ipertensione arteriosa esseniale 148
I farmaci beta-bloccanti riducono il release di brain natriuretic peptide dopo bypass aortocoronarico 148
Neurogenic abnormalities in masked hypertension 147
Nicorandil, a new vasodilator drug, in patients with essential hypertension 144
Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensive 140
Sympathetic activation characterized the metabolic syndrome independently on the obese state 137
Nadolol prevents the exercise-induced rise in lymphocyte beta-receptor number in borderline hypertension 137
Effetti del diabete mellito sul profilo neurologico e barorecettivo riflesso dello scompenso cardiocircolatorio 136
Mechanisms responsible for sympathetic activation by cigarette smoking in humans 136
Comparison between reproducibility and sensitivity of muscle sympathetic nerve traffic and plasma noradrenaline in man 134
Effect of octreotide on catecholamine plasma levels in patients with chromaffin cell tumors 134
Antihypertensive and water and sodium balance effects of felodipine, a new vasodilating calcium antagonist, in hypertensive patients 131
Effects of hypertension and obesityon the sympathetic activation of heart failure patients 130
Preservation of the baroreceptor heart rate reflex by chemical sympathectomy in experimental heart failure 130
Nicorandil, a new vasodilator drug, in patients with essential hypertension 130
Acute and chronic converting enzyme inhibition reduces the vasomotor response to reflex sympathetic activation in man 129
Modificazioni del profilo neuroadrenergico e barorecettivo riflesso dello scompenso cardiocircolatorio indotte dal diabete mellito 128
Nadolol prevents the exercise-induced rise in lymphocyte beta-receptor number in borderline hypertension 127
Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome 126
La presenza di apnee ostruttive notturne potenzia le disfunzioni metaboliche e neuroadrenergiche della sindrome metabolica 125
Short versus long-term effects of different dihydropyridines on sympathetic and baroreflex function in hypertension 125
Effects of different sodium intakes on the antihypertensive and renal effects of single oral doses of nifedipine in hypertensive patients 125
Obstructive sleep apnea-dependent and-independent adrenergic activation in obesity 124
Cigarette smoking and the adrenergic nervous system 124
Caratteristiche strutturali e funzionali delle arteriole di resistenza in soggetti obesi ipertesi 122
Caratteristiche strutturali e funzionali delle arteriole sottocutanee in soggetti con sindrome metabolica 122
Response to sympathetic activity, heart failure, obesity, and metabolic syndrome : is there any role for sleep apnea? 121
Kinetics of catecholamines and potassium, and heart rate during exercise testing in obese subjects. Heart rate regulation in obesity during exercise 121
Early effects of total paracentesis and albumin infusion on muscle sympathetic nerve activity in cirrhotic patients with tense ascites 121
Effects of diabetes mellitus on the sympathetic and baroreflex alterations in heart failure 119
Effects of celiprolol on reflex control of the cardiovascular system in essential hypertension 119
Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites 119
Effects of obesity and metabolic syndrome on the structural and functional characteristcs of subcutaneous small arteries in man 118
Effect of angiotensin converting enzyme inhibition on cardiovascular regulation during reflex sympathetic activation in sodium-replete patients with essential hypertension 118
Old and new approaches for evaluating autonomic control of circulation in man 118
Sympathetic activation and baroflex dysfunction in the metabolic syndrome 117
Clinical and functional correlates of platelet cyclic GMP in essential hypertensives 116
Cardiopulmonary receptor regulation of renin release 115
Sleep apnoea syndrome potentiates the neuroadrenergic and metabolic alterations characterizing patients whith metabolic syndrome 113
[Major hypoproteinemia revealing enteritis caused by Yersinia enterolytica and cytomegalovirus at the onset of chronic lymphocytic leukemia] 113
Effects of metabolic syndrome on the structural and functionl characteristic of subcutaneous small arteries in man 111
Effects of ageing on the cardiopulmonary receptor reflex in normotensive humans 110
Metabolic aspects and sympathetic effects in the obese subject undergoing exercise testing 110
Effect of detraining on the cardiopulmonary reflex in professional runners and hammer throwers 110
Effects of obesity complicated by hypertension on subcutaneous small arteries in man 107
Alterations in sympathetic nerve traffic during cigarette-smoking in man: a preliminary report 106
Alterations in sympathetic nerve traffic during cigarette-smoking in man: a preliminary report 106
Metabolic aspects and sympathetic effects in the obese subject undergoing exercise testing 105
Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans 105
Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure 103
Sympathetic activation in obese normotensive subjects 102
Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives 101
Cardiac hypertrophy impairs cardiac receptor control of circulation in man 99
Effetti della sindrome metabolica sulle caratteristiche struturali e funzionali delle arteriole sottocutanee nell'uomo 98
Sympathetic activation in obese normotensive subjects 96
Early sympathetic activation in mild renal failure 95
Sympathetic nerve traffic and baroreflex control of circulation in obese patients: a preliminary report 95
Totale 18.791
Categoria #
all - tutte 45.752
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.752


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021122 0 0 0 0 0 0 0 0 0 0 0 122
2021/2022841 67 45 37 48 52 31 75 46 76 92 54 218
2022/20231.541 159 102 111 203 178 298 55 107 156 43 79 50
2023/2024976 28 75 56 63 192 52 98 77 42 38 138 117
2024/20252.273 116 249 51 245 155 105 79 270 134 168 198 503
2025/20265.019 496 229 490 372 489 368 691 365 482 389 371 277
Totale 19.595